News from vantia therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Oct 03, 2017, 07:00 ETVantia Therapeutics Announces Positive Results From its Phase III EQUINOC Study, a Pivotal Trial with Fedovapagon for the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia

Vantia Therapeutics announces positive top-line data from a pivotal Phase III trial investigating the efficacy and safety of fedovapagon (VA106483)...


Jul 06, 2011, 04:00 ETVantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need, today...


Feb 02, 2010, 06:35 ETVantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial for Nocturia

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today...